Name of the Wave: Cardiomyopathy
Date of the Wave: 10th of November 2024
Time: 20:00 – 21:30 (GMT+4) UAE Time
Dr. Mohammed El-Harari
Graduated from Tripoli medical school, obtained his MRCP and FRCP from UK. and did his cardiology training in the North East of England obtaining his certificate of completion of specialty training (CCST) in cardiology in July 2001, following which he took a consultant cardiologist post at the university Hospital of north Durham in UK for 15 years till April 2016 when he moved to Saudi Arabia where he did 2 years consultant cardiologist post in Dr Suleiman al Habib in Riyadh, from where he moved to UAE in April 2018 as a consultant cardiologist in Al Ain Hospital as a head of the non-invasive department and where he have established a new multidisciplinary heart failure service. Since July of 2020, he moved to Tawam Hospital where he has established a new Heart failure clinic and working on establishing a multidisciplinary heart failure service.
Also, he has been appointed as the chair of the heart failure group of the UAE for the years 2022-2024.
Dr. Hussam Ghalib
is a Consultant Cardiologist and Director of the Cardiomyopathy Center at Cleveland Clinic Abu Dhabi (CCAD), specializing in heart failure and transplant cardiology since July 2017. He also serves as Director of Inpatient Services at the Heart, Vascular & Thoracic Institute (HVTI) at CCAD since January 2022. His expertise includes managing complex cardiovascular conditions and leading multidisciplinary teams in advanced heart failure treatments and heart transplantation. Previously, Dr. Ghalib worked as a Consultant Internist at the University of Michigan Hospital from 2009 to 2012, where he provided comprehensive inpatient care and contributed to clinical research and education in internal medicine.
Dr. Anna Kostareva
has been the Director of the Institute of Molecular Biology and Genetics at the Almazov Medical Research Centre in Saint Petersburg, Russia, since 2009. Additionally, she serves as an Associate Professor at Oslo University in Norway and at Pavlov Medical University and Almazov Research Centre in Russia, both since 2015, with a commitment of 0.25%. Since 2007, she has also held the position of Visiting Scientist at the Karolinska Institutet in Stockholm, Sweden, in the Department of Woman and Child Health. Previously, in 2006, she was a Principal Investigator at the Almazov Medical Research Centre’s Laboratory of Cell Therapy.
- 20:00
Introduction - 20:05 – 20:25
HCM center of excellence: The goals and requirements
Dr Hussam Ghalib - 20:25 – 20:45
Rare forms of cardiomyopathies in the light of new classification: secondary, syndromic or phenocopies?
Dr. Anna A. Kostareva - 20:45 – 21:05
New frontiers in the medical management of HCM “Symposium Sponsored by BMS”
Dr. Mohamed El-Harari - 21:05 – 21:30
Open Discussion
